Aino Telaranta-Keerie
Senior Director, Global Precision Medicine Lead Astellas Pharma
Aino Telaranta-Keerie has worked 20+ years in the pharmaceutical and diagnostic industries, with 10+ years’ experience as Precision Medicine leader in oncology at AstraZeneca and Astellas. She is passionate about optimising CDx partnerships and strategies to ensure successful development of new therapies for patients.
Seminars
Tuesday 31st March 2026
Enabling Pharma Compliance with IVDR for Precision Medicine Trials
5:50 pm
- How can pharma build IVDR capabilities to effectively deliver precision medicine trials in the EU?
- How to achieve IVDR compliance for trials with or without diagnostic company involvement?
- How to enable smooth collaboration between pharma, IVD manufacturer and/or CRO(s) for National Competent Authority submissions and approvals?
